|
Licensing, Collaborative and Other Arrangements (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | |
|---|---|---|
|
Sep. 30, 2010
|
Sep. 30, 2012
|
|
|
Development Milestone [Member]
|
||
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||
| Amount due upon achievement of milestone | 8.5 | |
|
Sales Milestone [Member]
|
||
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||
| Amount due upon achievement of milestone | 15.1 | |
|
Collaborative Arrangement [Member]
|
||
| Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | ||
| Number of fixed-dose combination product candidates included in a portfolio of antihypertensive products from Servier | 3 | |
| License fees paid | $ 1.5 |